N-(Pyrazin-2-ylcarbonyl)glycine
CAS: 57229-37-5
Ref. 3D-HCA22937
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued | ||
| 2500mg | Discontinued |
Product Information
Name:
N-(Pyrazin-2-ylcarbonyl)glycine
Synonyms:
- Glycine, N-pyrazinoyl-
- N-(2-Pyrazinylcarbonyl)glycine
- Glycine, N-(2-pyrazinylcarbonyl)-
- Glycine, N-(pyrazinylcarbonyl)-
- Pyrazinoylglycine
Description:
N-(Pyrazin-2-ylcarbonyl)glycine (PZAG) is a prodrug that is converted to pyrazinoic acid in vivo. It is an inhibitor of HIV protease and has been shown to have a pharmacokinetic profile suitable for once-daily administration. PZAG has also been shown to inhibit the production of uric acid, which may be due to its ability to inhibit deamidases that produce uric acid from purines. PZAG may interact with other drugs, such as antibiotics, which are involved in the elimination phase of drug metabolism.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
181.15 g/mol
Formula:
C7H7N3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
